This National Cancer Institute grant is aimed at funding research to assess and improve the utilization, delivery, and adherence of oral anticancer medications. The research should focus on identifying barriers to adherence, developing strategies for effective delivery, and optimizing clinical outcomes. Projects may target specific cancer types, drug classes, or populations with disparities. Research can be conducted at various levels and may include intervention, observational, or mixed-methods studies emphasizing modifiable risk factors. Applications are open until January 7, 2020.
Opportunity ID: 298359
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-18-014 |
| Funding Opportunity Title: | Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 03, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 07, 2020 |
| Current Closing Date for Applications: | Jan 07, 2020 |
| Archive Date: | Feb 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Public and State controlled institutions of higher education State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities City or township governments Small businesses Independent school districts Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to encourage exploratory/developmental research grant applications to: (1) assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; (2) identify structural, systemic, and psychosocial barriers to adherence; and (3) develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized. Applications should focus research questions on at least one of the following: specific cancer type; class of drugs; and/or groups subject to disparities (e.g., elderly populations, members of low socioeconomic groups, racial/ethnic minorities). Research may be focused at the patient (pediatric, adolescent, or adult), patient-caregiver, provider, health care team, or health care delivery system level, and may include intervention studies, observational studies, or mixed-methods studies. Observational studies should emphasize modifiable risk factors for future intervention research. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-014.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00235692 | Jan 17, 2018 | Jan 07, 2020 | View |
Package 1
Mandatory forms
298359 RR_SF424_2_0-2.0.pdf
298359 PHS398_CoverPageSupplement_4_0-4.0.pdf
298359 RR_OtherProjectInfo_1_4-1.4.pdf
298359 PerformanceSite_2_0-2.0.pdf
298359 RR_KeyPersonExpanded_2_0-2.0.pdf
298359 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
298359 RR_Budget_1_4-1.4.pdf
298359 RR_SubawardBudget30_1_4-1.4.pdf
298359 PHS398_ModularBudget_1_2-1.2.pdf
298359 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
